Bactrim DS 800-160
Safety of Adverse Events:
Because this drug is not intended for human use, it is not meant to be used when the patient is in need. However, if there is an indication for a potentially significant risk to the health of the patient, it may be appropriate to seek medical attention.
The following side effects were reported in patients not requiring antibiotics despite prior use of Bactrim:
Erythema multiforme and pulmonary edema/epigastric ulcer
Hepatosintolerance, with or without renal impairment
Liver or renal disease in patients with history of use ≥ 8 weeks, including > 7 consecutive days within 1 week period of Bactrim.
The following side effects have been reported when the side-effect profile (SAD) changed over time:
An increased risk of death or permanent disability due to the patient being at increased risk of sudden cardiac death and sudden cardiac arrest
Encephalocele, although no data are available, which is more likely due to the higher prevalence of these types of cases in patients who may have received treatment as part of Bactrim therapy (e.g., at higher doses, for treatment of other respiratory infections or viral infections) than due to changes in the number of instances resulting from Bactrim therapy, bactrim ds 800-160.
Decreased quality of life in patients with ECTA associated with reduced patient compliance or decreased adherence to therapy. (See patients with ECTA associated with decreased quality of life).
Injection of Bactrim into the A single dose is used for each patient, typically one dose in a 2-hour period. Antibiotics are recommended for the treatment of bacterial overgrowth (BOP) caused by certain strains of Gram-negative bacteria, such as Clostridium difficile.